Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia
Author:
Affiliation:
1. Department of Investigative Endocrinology , St. Vincent’s University Hospital , Dublin , Ireland
2. Clinical Biochemist , retired , Chiltern House, Bury St Edmonds , Suffolk , UK
Abstract
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Link
https://www.degruyter.com/document/doi/10.1515/cclm-2022-0459/pdf
Reference36 articles.
1. Fahie-Wilson, M, Smith, TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab 2013;27(5):725–42, https://doi.org/10.1016/j.beem.2013.07.002.
2. Wallace, IR, Satti, N, Courtney, CH, Leslie, H, Bell, PM, Hunter, SJ, et al.. Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. J Clin Endocrinol Metab 2010;95(7):3268–71, https://doi.org/10.1210/jc.2010-0114.
3. McKenna, TJ. Should macroprolactin be measured in all hyperprolactinaemic sera? Clin Endocrinol (Oxf) 2009;71(4):466–9, https://doi.org/10.1111/j.1365-2265.2009.03577.x.
4. Hattori, N, Aisaka, K, Shimatsu, A. A possible cause of the variable detectability of macroprolactin by different immunoassay systems. Clin Chem Lab Med 2016;54:603–8. https://doi.org/10.1515/cclm-2015-0484.
5. Hattori, N, Ishihara, T, Saiki, Y. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clin Endocrinol (Oxf) 2009;71:702–8. https://doi.org/10.1111/j.1365-2265.2009.03570.x.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Macroprolactin in mothers and their babies: what is its origin?;Clinical Chemistry and Laboratory Medicine (CCLM);2024-04-30
2. Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365–72;Clinical Chemistry and Laboratory Medicine (CCLM);2022-09-05
3. Letter to the Editor relating to Clin Chem Lab Med 2022;60(9):1365–72;Clinical Chemistry and Laboratory Medicine (CCLM);2022-09-02
4. Interference by macroprolactin in assays for prolactin: will the In Vitro Diagnostics Regulation lead to a solution at last?;Clinical Chemistry and Laboratory Medicine (CCLM);2022-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3